Showing 81–84 of 84 resultsSorted by latest
-
December of 2018This Target Pipeline List provides an overview of antibodies targeting interleukin-33 (IL-33) or its receptor ST2 (IL1RL1) in clinical development for treatment of atopic diseases.€ 75.00
-
May of 2018This report brings you up-to-date regarding key TCR-T players, technologies and product candidates, business models, deals and funding opportunities and analyzes the TCR-T pipelines and stakeholders in the field.€ 2150.00
-
January of 2018This report informs you about key technologies to identify and validate intracellular targets, to generate TCRs and TCR fusion proteins, to discover TCR-like antibodies, and construct cell-penetrating peptides, proteins and...
€ 2300.00Original price was: € 2300.00.€ 2000.00Current price is: € 2000.00. -
January of 2019This Target Pipeline List provides an overview of agonist antibodies and fusion proteins targeting death receptor 4 and/or 5 in development for treatment of cancer.€ 100.00